[Rick] had a problem. His garage refrigerator was tasked with a critical duty—keeping refreshing beverages at low temperature. Unfortunately, it had failed—the condenser was forever running, or not ...

Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the range of services it can deliver.

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...